SAN DIEGO — Erinn Maury knew Remicade wasn’t the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte’s swollen, painful joints hadn’t responded to Enbrel or Humira, two drugs in the same class. But the insurer insisted, so Schulte went on Remicade. It didn’t work either....
Sara Novak One of the biggest challenges facing clinicians who treat long COVID is a lack of consensus when it comes to recognizing and diagnosing the condition. But a new study suggests testing for certain biomarkers may identify long COVID with accuracy approaching 80%. Effective diagnostic testing would be a game-changer in the long COVID...
Dr Sheena Meredith, MB BS, MPhil | Disclosures | 05 April 2023 A new non-invasive diagnostic test for oral cancer test developed by researchers at the University of Surrey is said to be over 92% accurate at detecting oral squamous cell carcinoma (OSCC) and more than 80% accurate at identifying pre-cancerous oral epithelial dysplasia (OED), according to a proof-of-concept...
by University of Edinburgh Credit: Unsplash/CC0 Public Domain Analyzing changes to DNA in the blood can improve the ability to predict a person’s risk of developing type 2 diabetes within a decade. Scientists looked at the influence of these changes—known as DNA methylation—alongside other risk factors in almost 15,000 people to predict the likelihood of...
When Srikanth Singamaneni and Guy Genin, both professors of mechanical engineering and materials science at the McKelvey School of Engineering at Washington University in St. Louis, established a new collaboration with researchers from the School of Medicine in late 2019, they didn’t know the landscape of infectious disease research was about to shift dramatically. The...
by Sonia Fernandez, University of California – Santa Barbara Bacterial infection results in catastrophic changes in blood proteins that can be used as a platform to develop rapid and easy-to-perform tests to predict sepsis for early intervention. Credit: University of California – Santa Barbara In a potential paradigm change for sepsis diagnostics, a new test predicted...
by Tufts University A blacklegged (deer) tick. Credit: Lennart Tange For scientists and clinicians alike, one of the Holy Grails for successfully treating and curing Lyme disease is developing tests that identify the disease sooner, show when people are cured of infection, and can diagnose reinfection. Now, researchers at Tufts University School of Medicine say...
JAMES COOK UNIVERSITY IMAGE: DR MARK PEARSON WITH SCHISTOSOMA HAEMATOBIUM – THE PARASITIC BLOOD FLUKES THAT SPREAD SCHISTOSOMIASIS CREDIT: PHOTO: ROMY BULLERJAHN Researchers have made important progress towards a new diagnostic test for schistosomiasis, which could help the World Health Organisation (WHO) achieve its goal of interrupting transmission of the disease, and eventually eliminating it....
by QIMR Berghofer Medical Research Institute Metastatic melanoma tumour cells showing low levels of LC38 (green) and high G9a (red) in Nonresponder to immunotherapy. Credit: QIMR Berghofer Medical Research Institute Researchers from QIMR Berghofer Medical Research Institute have developed a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy. Details about the test...
by Florence Meney, University of Montreal Myalgic encephalomyelitis (ME), better known as chronic fatigue syndrome, is a complex chronic disease affecting some 600,000 Canadians and up to 2.5 million Americans. It’s also poorly understood: until now there has been no validated blood biomarker or test to diagnose the disease. Researchers at CHU Sainte-Justine and Université de Montréal...
